期刊文献+

FOLFOX6方案联合鸦胆子油乳治疗转移性大肠癌的临床观察 被引量:9

FOLFOX6 Regimen Combined with Bruceolic Oil Emulsion in the Treatment of Metastatic Large Intestine Carcinoma
暂未订购
导出
摘要 目的观察FOLFOX6方案联合鸦胆子油乳治疗转移性大肠癌的临床疗效和毒副反应。方法 41例转移性大肠癌患者随机分为2组,治疗组采用FOLFOX6方案联合鸦胆子油乳治疗,对照组仅采用FOL-FOX6方案化疗,比较观察2组的临床疗效和毒副反应。结果治疗组、对照组有效率分别为50.0%和42.9%,差异无统计学意义(P>0.05);治疗组骨髓抑制发生率为45.0%,低于对照组的71.4%,差异有统计学意义(P<0.05);治疗组生活质量改善率高于对照组,差异有统计学意义(P<0.05)。结论 FOLFOX6方案联合鸦胆子油乳治疗转移性大肠癌有效,可提高患者的生活质量和减轻化疗毒副反应。 Objective To study the clinical efficacy and toxicities of FOLFOX6 regimen combined with bruceolic oil emulsion in the treatment of metastatic large intestine carcinoma. Methods Forty one patients with metastatic large intestine carcinoma were divided into two groups, the 20 patients in the treatment group were treated with FOL- FOX6 regimen and bruceolic oil emulsion, the 21 patients in the control group were treated with FOLFOX6 regimen, the efficacy and toxicities of the two groups were compared. Results The effective rates in the treatment group and the control group were 50.0% and 42.9% respectively, there was no significant difference between the two groups ( P 〉 0.05 ). The incidence of bone marrow suppression in the treatment group ( 45.0% ) was significantly lower than that in the control group (71.4%) (P 〈 0.05 ). The improvement rate of quality of life in the treatment group was significantly higher than that in the control group (P 〈 0.05). Conclusion FOLFOX6 regimen combined with bruceolic oil emulsion is effective in the treatment of metastatic large intestine carcinoma, it can improve the quality of life and reduce the chemotherapy related toxicities.
出处 《肿瘤基础与临床》 2013年第1期16-18,共3页 journal of basic and clinical oncology
关键词 奥沙利铂 5-氟尿嘧啶 鸦胆子油乳 转移性大肠癌 化疗 oxaliplatin 5-fluorouracil bruceolic oil emulsion metastatic large intestine carcinoma chemotherapy
  • 相关文献

参考文献5

二级参考文献13

  • 1De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
  • 2Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
  • 3Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
  • 4De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
  • 5De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
  • 6Jung HY,Shim HJ,Kwak BK,et al. Percutaneously implantable catheter-port system for chemotherapeutic infusion through the hepatic artery[J].Am J Roentgenol,1999,172(3):641-644.
  • 7Terashima M,Takagane A,Ikeda K,et al. Pharmacokinetic analyses of intraarterial and intraportal chemotherapeutic agent infusion [J].Gan To Kagaku Ryoho, 1996 ,23(11):1499-1501.
  • 8Yamano T,Takayasu Y,Nakao N,et al. Evaluation of hepatic toxicity following high-dose 5-Fu arterial infusion chemotherapy:analysis of 42 cases of colorectal liver metastases [J].Nippon Igaku Hoshasen Gakkai Zasshi,2000,60(3):94-102.
  • 9李笑弓,南勋义,党建功,李旭,杨少毅.鸦胆子油静脉乳剂对人肾癌影响的实验研究[J].临床泌尿外科杂志,1998,13(2):82-84. 被引量:31
  • 10孙燕,管忠震,金懋林,李维廉,李丽庆,石廷章,周立中,隋广杰,许立功,宋恕平,许德凤,李容,李扬,黄富麟,张嘉庆,张和平,Brienza S,鞠利雅.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].癌症,1999,18(3):237-240. 被引量:347

共引文献532

同被引文献314

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部